FDA Approves Futibatinib for Certain Biliary Tract Cancers :

The indication is for use in adult patients with previously treated intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements.

Related Keywords

United States , Massachusetts , Lipika Goyal , Hospital Cancer Center , Drug Administration , Massachusetts General Hospital Cancer Center , Hepatocellular Carcinoma , Liver Cancer , Dcc , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Cholangiocarcinoma , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Abdominal Pain , Cancer , Alignant Neoplasia , Arcinoma , Grant , Neoplasm , Pain Management , Toxicology , Tumor , Gu ,